Relmada Therapeutics, Inc. (RLMD)
7.01
+0.26
(+3.85%)
USD |
NASDAQ |
Apr 08, 16:00
7.01
0.00 (0.00%)
After-Hours: 18:07
Relmada Therapeutics Price : 7.01 for April 8, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Catalyst Pharmaceuticals, Inc. | 25.32 |
| Theravance Biopharma, Inc. | 16.61 |
| Avalo Therapeutics, Inc. | 14.43 |
| AN2 Therapeutics, Inc. | 3.35 |
| ACADIA Pharmaceuticals, Inc. | 22.59 |
Price Related Metrics
| Price to Book Value | 8.314 |
| Earnings Yield | -21.43% |
| Market Cap | 735.28M |